Topic - Phlow Corp.

Related Stories

This 2019 photo provided by Civica Rx shows vials of vancomycin in Lehi, Utah. Impatient with years of inaction in Washington on prescription drug costs, U.S. hospital groups, startups and nonprofits have started making their own medicines in a bid to combat stubbornly high prices and persistent shortages of drugs with little competition. (Civica Rx via AP)

Groups make own drugs to fight high drug prices, shortages

By Linda A. Johnson - Associated Press

This illustration provided by the Centers for Disease Control and Prevention (CDC) in January 2020 shows the 2019 Novel Coronavirus (2019-nCoV). (CDC via AP, File)

Richmond, Va., company wins contract to make key COVID-19 drug supplies in U.S.

By David Sherfinski - The Washington Times

This April 9, 2012 photo provided by Virginia Commonwealth University Relations shows Dr. Frank Gupton, PhD., co-founder of Phlow, chair of Virginia Commonwealth University's Department of Chemical and Life Science Engineering and CEO of the Medicines for All Institute, in Richmond, Va. The Department of Health and Human Services announced Tuesday, May 19, 2020, it was awarding a contract worth up to $812 million to Richmond-based Phlow to manufacture pharmaceutical ingredients, chemical compounds and generic drugs inside the United States. (Thomas Kojcsich/Virginia Commonwealth University School of Engineering)

Small Virginia company gets huge federal medicines contract

By ALAN SUDERMAN and LINDA A. JOHNSON - Associated Press